A joint project to strengthen the pharmaceutical sector in Mexico was delivered to the EU
The European Union together with Mexico will have a project that will open research, development and production of medical supplies and vaccines. This project would open the opportunity for Mexico to establish itself as a reference country in the research, development and production of medical supplies and vaccines. It is expected that the project could start up in the next month of September.
Within the framework of the close relations between Mexico and the European Union (EU), derived from the COVID-19 pandemic, on July 5 in Brussels, Belgium, the Undersecretary for Multilateral Affairs and Human Rights of the SRE, Martha Delgado Peralta, made the symbolic delivery of the joint project “Preparing for Current and Future Pandemics” to Jolita Butkeviciene, director for Latin America and the Caribbean of the General Directorate of International Alliances of the European Commission.
Mexico and the European Union have developed various strategies to counteract the negative impact of the pandemic on societies, which have materialized through the Agreement for Political Coordination, Economic Association and Cooperation, also known as the “Global Agreement”, as well as the Mexico-European Union Joint Fund.
Through this linkage mechanism, this long-term collaboration project was presented, whose purpose is to develop and improve national capacities for the manufacture of medicines, medical devices and vaccines. It also seeks to strengthen access and availability of essential supplies required by the population in preparation for current and future pandemics. This project has been developed since December 2021 through the General Directorate for Global Economic Impulse of the SRE, in conjunction with the European Commission.
Within the project, it is planned to develop an analysis to define market opportunities, identify the state of the current infrastructure and discover the potential of the pharmaceutical and medical device sectors. The development of a “hub” is proposed to share EU experiences in local manufacturing and industrial development, as well as in other innovations that require regional work through which there is an exchange of information on compliance and business models carried out in contexts and similar situations.
Source: Luces del Siglo.
The major issues for the further development of the pharmaceutical market will be discussed at the Mexican Pharmaceutical Forum that will be organized by the Global Pharmaceutical Leaders’ Club on the 29-30th November 2022 in Mexico City. Secure your delegate place ASAP! Registration is here: https://mexicanpharmaforum.com/registration/
Takeda appoints Hernán Porcile as its new General Manager in Mexico
October 24, 2022
Solid growth of the Medical Devices sector in Mexico
October 19, 2022
Sandoz Receives Certification for Transparent Practices
October 19, 2022